Geno SA

Geno SA is an innovative genetic organization with a strong focus on genetic improvement of the Norwegian Red breed, specializing in traits such as fertility, disease resistance, and production through its HD Genomics breeding program. The company boasts a rich history of over 80 years of breeding planning since 1935, and is dedicated to providing dairy farmers with reliable genetics for efficient and economical operations. Operating in more than 30 countries with a workforce of 230 employees, Geno SA works closely with customers to provide sustainable protein production and world-leading genetics. The company's R&D team collaborates with world-leading researchers, resulting in various research projects and numerous doctorate degrees, establishing the basis for the success of the Norwegian Red breed. Additionally, Geno SA owns 52% of Cryogentics Ltd. and also operates Geno Global Ltd. and SpermVital Ltd. (www.spermvital.com). The company's commitment to breeding for better lives, for both dairy farmers and cattle, reflects in its extensive efforts and impact in the industry.